SCHEMBL23515005

SCHEMBL23515005

COC(=O)Cc1nc(C)c(S(C)(=O)=O)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.44
HSD17B10 Q99714 1/20 0.44
GAA P10253 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
KDM4E B2RXH2 1/20 0.32
KDM5B Q9UGL1 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA3 P07451 2/20 0.32
CA4 P22748 2/20 0.32
CA6 P23280 2/20 0.32
CA5A P35218 2/20 0.32
CA7 P43166 2/20 0.32
CA9 Q16790 2/20 0.32
CA13 Q8N1Q1 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL408093 0.78 HTT (0.50) HTTHSD17B10GAANPSR1L3MBTL1
Bromide SCHEMBL7406625 0.71 HTT (0.43) HTTHSD17B10GAANPSR1L3MBTL1
SCHEMBL2890226 0.67 F2 (0.39) HTTL3MBTL1RAB9ACA12CA1
SCHEMBL10125972 0.66 PIK3CG (0.57) SMN1; SMN2ALDH1A1HPGD
SCHEMBL1640359 0.66 ALDH1A1 (0.34) HTTHSD17B10GAARAB9ACA12
SCHEMBL18256147 0.65 GAA (0.43) HTTHSD17B10GAAL3MBTL1NPC1
SCHEMBL3008519 0.64 HSD17B10 (0.57) HTTHSD17B10NPSR1NPC1RAB9A
SCHEMBL13208839 0.64 HSD17B10 (0.45) HTTHSD17B10NPC1RAB9AKDM4E
SCHEMBL11325797 0.63 RAB9A (0.59) HTTGAAL3MBTL1NPC1RAB9A
SCHEMBL4028624 0.62 MAPT (0.62) HTTHSD17B10GAAL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021116260-A1 QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2021-06-17 WO disclosed